50th week of 2016 patent applcation highlights part 18 |
Patent application number | Title | Published |
20160362394 | CARBAMATE-SUBSTITUTED OXINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF VASOPRESSIN-DEPENDENT DISEASES | 2016-12-15 |
20160362395 | INDOLE, INDAZOLE AND BENZIMIDAZOLE ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | 2016-12-15 |
20160362396 | QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS | 2016-12-15 |
20160362397 | COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | 2016-12-15 |
20160362398 | AMIDE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2016-12-15 |
20160362399 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2016-12-15 |
20160362400 | AVANAFIL PREPARATION METHOD | 2016-12-15 |
20160362401 | PROCESS FOR TOTAL SYNTHESIS OF FLAVONOID COMPOUNDS AND ISOMERS THEREOF | 2016-12-15 |
20160362402 | NOVEL COMPOUNDS HAVING ANTI-ALLODYNIC AND ANTIHYPERALGESIC ACTIVITY | 2016-12-15 |
20160362403 | NOVEL DISUBSTITUTED 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE COMPOUNDS FOR USE IN THE TREATMENT OF CHEMOKINE-MEDIATED DISEASES | 2016-12-15 |
20160362404 | NEW COMPOUNDS | 2016-12-15 |
20160362405 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2016-12-15 |
20160362406 | HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER | 2016-12-15 |
20160362407 | HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 AND THEIR USE IN THE TREATMENT OF CANCER | 2016-12-15 |
20160362408 | ARYL- AND HETARYL-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDES AND USE THEREOF | 2016-12-15 |
20160362409 | N2-PHENYL-PYRIDO[3,4-D]PYRIMIDINE-2, 8-DIAMINE DERIVATIVES AND THEIR USE AS MPS1 INHIBITORS | 2016-12-15 |
20160362410 | PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE | 2016-12-15 |
20160362411 | PROCESSES FOR MAKING PONATINIB AND INTERMEDIATES THEREOF | 2016-12-15 |
20160362412 | IDO Inhibitors | 2016-12-15 |
20160362413 | POLYMORPHIC FORM OF ALCAFTADINE, COMPOSITION AND PROCESS | 2016-12-15 |
20160362414 | MACROCYCLES AS FACTOR XIA INHIBITORS | 2016-12-15 |
20160362415 | POLYMORPHIC FORMS OF NALTREXONE | 2016-12-15 |
20160362416 | ANTIVIRAL COMPOUNDS | 2016-12-15 |
20160362417 | Process for the Preparation of 5-Fluorotryptophol | 2016-12-15 |
20160362418 | CARBOXAMIDE-SUBSTITUTED XANTHENE DYES | 2016-12-15 |
20160362419 | POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS | 2016-12-15 |
20160362420 | Antiparasitic Compositions and Methods Utilizing Substituted 5,5,7,7-Tetramethyl- 4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine Derivatives | 2016-12-15 |
20160362421 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | 2016-12-15 |
20160362422 | BROAD SPECTRUM BETA-LACTAMASE INHIBITORS | 2016-12-15 |
20160362423 | 7-OXO-THIAZOLOPYRIDINE CARBONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | 2016-12-15 |
20160362424 | SALTS OF (S)-7-(1-(9H-PURIN-6-YLAMINO)ETHYL)-6-(3-FLUOROPHENYL)-3-METHYL-5- H-THIAZOLO[3,2-A]PYRIMIDIN-5-ONE | 2016-12-15 |
20160362425 | CRYSTALLINE FORMS OF A PI3K INHIBITOR | 2016-12-15 |
20160362426 | PROCESS FOR THE SYNTHESIS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR | 2016-12-15 |
20160362427 | BRIDGED BICYCLIC KALLIKREIN INHIBITORS | 2016-12-15 |
20160362428 | Synthesis and Isolation of Crystalline Alkali Metal Arene Radical Anions | 2016-12-15 |
20160362429 | HALOGEN FREE SYNTHESIS OF AMINOSILANES BY CATALYTIC DEHYDROGENATIVE COUPLING | 2016-12-15 |
20160362431 | Carbidopa And L-Dopa Prodrugs And Methods Of Use | 2016-12-15 |
20160362432 | PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2016-12-15 |
20160362433 | ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2016-12-15 |
20160362434 | METHODS AND COMPOUNDS FOR ENHANCING CONTRAST IN MAGNETIC RESONANCE IMAGING (MRI) | 2016-12-15 |
20160362435 | PROCESS FOR ISOLATING FERMENTABLE SUGARS FROM THE ACID HYDROLYZATE OF A MATERIAL CONTAINING CELLULOSE, HEMICELLULOSE AND LIGNIN | 2016-12-15 |
20160362436 | SIALIC ACID DERIVATIVES | 2016-12-15 |
20160362437 | Method for Producing Lentztrehalose A, Compound Useful for the Method, and Method for Producing the Compound | 2016-12-15 |
20160362438 | 5-FORMYLCYTOSINE SPECIFIC CHEMICAL LABELING METHOD AND RELATED APPLICATIONS | 2016-12-15 |
20160362439 | CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS | 2016-12-15 |
20160362440 | Synthesis of Protected 3'-Amino Nucleoside Monomers | 2016-12-15 |
20160362441 | CYCLIC DINUCLEOTIDES FOR CYTOKINE INDUCTION | 2016-12-15 |
20160362442 | Method For DHEA Enanthate Processing | 2016-12-15 |
20160362443 | Method For DHEA Enanthate Processing | 2016-12-15 |
20160362444 | Method for Treating Diabetes | 2016-12-15 |
20160362445 | SOLID PHASE PEPTIDE SYNTHESIS VIA SIDE CHAIN ATTACHMENT | 2016-12-15 |
20160362446 | ANTIBODY PURIFICATION PROCESS | 2016-12-15 |
20160362447 | METHODS FOR REDUCING AGGREGATE CONTENT OF PROTEIN PREPARATIONS BY TREATMENT WITH ARYL ANIONS | 2016-12-15 |
20160362448 | METHODS FOR REDUCING CHROMATIN CONTENT IN PROTEIN PREPARATIONS BY TREATMENT WITH ALKYL CATIONS | 2016-12-15 |
20160362449 | SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS | 2016-12-15 |
20160362451 | SELF-ASSEMBLING PEPTIDE COMPOSITIONS | 2016-12-15 |
20160362452 | SYNTHETIC PEPTIDE FOR REPRESSING TRANSCRIPTION AND/OR GENE EXPRESSION FROM A BINDING SITE OF INTEREST | 2016-12-15 |
20160362453 | RECOMBINANT BINDING PROTEINS AND THEIR USE | 2016-12-15 |
20160362454 | Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses | 2016-12-15 |
20160362455 | INFLUENZA VIRUS VACCINES AND USES THEREOF | 2016-12-15 |
20160362456 | MODIFIED MICROORGANISMS FOR CHEMICAL PRODUCTION | 2016-12-15 |
20160362457 | Immunogenic Proteins and Compositions | 2016-12-15 |
20160362458 | MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS | 2016-12-15 |
20160362459 | ANTIMICROBIAL PEPTIDES | 2016-12-15 |
20160362460 | MULTI-SPECIFIC POLYPEPTIDE USEFUL FOR LOCALIZED TUMOR IMMUNOMODULATION | 2016-12-15 |
20160362461 | KIDNEY DISEASE TARGETS AND USES THEREOF | 2016-12-15 |
20160362462 | Modification and Novel Compositions of Human Secretoglobin Proteins | 2016-12-15 |
20160362463 | Pharmaceutical composition inhibiting interaction between MZF-1 and Elk-1 | 2016-12-15 |
20160362464 | NOVEL THERAPEUTIC TARGETS FOR CANCER PROGRESSION | 2016-12-15 |
20160362465 | WT1 ANTIGENIC POLYPEPTIDE, AND ANTI-TUMOR AGENT CONTAINING SAID POLYPEPTIDE | 2016-12-15 |
20160362466 | PEPTIDES HAVING OSTEOBLAST GROWTH-PROMOTING ACTIVITY AND USE THEREOF | 2016-12-15 |
20160362467 | APRIL VARIANTS | 2016-12-15 |
20160362468 | NATRIURETIC POLYPEPTIDES | 2016-12-15 |
20160362469 | Methods for protein modification in pharmaceutical applications | 2016-12-15 |
20160362470 | Recombinant Fusion Proteins and Libraries from Immune Cell Repertoires | 2016-12-15 |
20160362471 | SHORTENED CD95-FC VARIANTS | 2016-12-15 |
20160362472 | CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL | 2016-12-15 |
20160362473 | IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF | 2016-12-15 |
20160362474 | IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF | 2016-12-15 |
20160362475 | UTI FUSION PROTEINS | 2016-12-15 |
20160362476 | METHODS AND COMPOSITIONS FOR PRODUCING A CHIMERIC POLYPEPTIDE | 2016-12-15 |
20160362477 | SECRETORY IGA COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF | 2016-12-15 |
20160362478 | CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIES | 2016-12-15 |
20160362479 | Broadly Neutralizing Monoclonal Antibodies Against HIV-1 V1V2 Env Region | 2016-12-15 |
20160362480 | NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE | 2016-12-15 |
20160362481 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE | 2016-12-15 |
20160362482 | COMPOSITIONS AND METHODS OF MODULATING B CELL RESPONSE | 2016-12-15 |
20160362483 | PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION | 2016-12-15 |
20160362484 | SELF-BUFFERING PROTEIN FORMULATIONS | 2016-12-15 |
20160362485 | SELF-BUFFERING PROTEIN FORMULATIONS | 2016-12-15 |
20160362486 | SELF-BUFFERING PROTEIN FORMULATIONS | 2016-12-15 |
20160362487 | Anti-IL-33 Antibodies and Uses Thereof | 2016-12-15 |
20160362488 | ANTI-PACAP ANTIBODIES AND USES THEREOF | 2016-12-15 |
20160362489 | Treatment of PD-L1-Positive Melanoma Using an Anti-PD-1 Antibody | 2016-12-15 |
20160362490 | ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME | 2016-12-15 |
20160362491 | BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES | 2016-12-15 |
20160362492 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PERSISTENT INFECTIONS AND CANCER BY INHIBITING THE PROGRAMMED CELL DEATH 1 (PD-1) PATHWAY | 2016-12-15 |
20160362493 | GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY | 2016-12-15 |
20160362494 | ICOS BINDING PROTEINS | 2016-12-15 |
20160362495 | Human Monoclonal Antibodies to Programmed Death Ligand 1 (PD-L1) | 2016-12-15 |